---
figid: PMC11058998__fphys-15-1377329-g003
figtitle: Piezo1 affects the occurrence and development of diseases through multiple
  signaling pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11058998
filename: fphys-15-1377329-g003.jpg
figlink: /pmc/articles/PMC11058998/figure/F3
number: F3
caption: 'Piezo1 affects the occurrence and development of diseases through multiple
  signaling pathways. It mainly works through three pathways: YAP signaling pathway,
  Akt signaling pathway and NF-κB signaling pathway. The three pathways regulate the
  progression of hepatocellular carcinoma, oral squamous cell carcinoma, prostate
  cancer, atherosclerosis and other diseases through different mechanisms. Abbreviation:
  JNK: C-Jun N-terminal kinase; MAPK: Mitogen-activated protein kinases; ERK 1/2:
  Extracellular signal-regulated kinase 1/2; mTOR: Mammalian target of rapamycin;
  eNOS: Endothelial nitric oxide synthase; PI3K: Phosphatidylinositol 3-kinase; FAK:
  Focal adhesion kinase; NLRP3: NOD-like receptor thermal protein domain associated
  protein 3; HCC: Hepatocellular carcinoma; OSCC: Oral squamous cell carcinoma; PCa:
  Prostatic carcinoma; PH: Pulmonary hypertension; IDD: Intervertebral disc disease;
  AS: Atherosclerosis'
papertitle: Pleiotropic physiological functions of Piezo1 in human body and its effect
  on malignant behavior of tumors
reftext: Yihan Zhang, et al. Front Physiol. 2024;15(NA).
year: '2024'
doi: 10.3389/fphys.2024.1377329
journal_title: Frontiers in Physiology
journal_nlm_ta: Front Physiol
publisher_name: Frontiers Media S.A.
keywords: Piezo1 | tumor | initiation and progression | metastasis | therapeutic target
automl_pathway: 0.8779247
figid_alias: PMC11058998__F3
figtype: Figure
redirect_from: /figures/PMC11058998__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11058998__fphys-15-1377329-g003.html
  '@type': Dataset
  description: 'Piezo1 affects the occurrence and development of diseases through
    multiple signaling pathways. It mainly works through three pathways: YAP signaling
    pathway, Akt signaling pathway and NF-κB signaling pathway. The three pathways
    regulate the progression of hepatocellular carcinoma, oral squamous cell carcinoma,
    prostate cancer, atherosclerosis and other diseases through different mechanisms.
    Abbreviation: JNK: C-Jun N-terminal kinase; MAPK: Mitogen-activated protein kinases;
    ERK 1/2: Extracellular signal-regulated kinase 1/2; mTOR: Mammalian target of
    rapamycin; eNOS: Endothelial nitric oxide synthase; PI3K: Phosphatidylinositol
    3-kinase; FAK: Focal adhesion kinase; NLRP3: NOD-like receptor thermal protein
    domain associated protein 3; HCC: Hepatocellular carcinoma; OSCC: Oral squamous
    cell carcinoma; PCa: Prostatic carcinoma; PH: Pulmonary hypertension; IDD: Intervertebral
    disc disease; AS: Atherosclerosis'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIEZO1
  - YAP1
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NLRP3
  - MTOR
  - MAPK8
  - MAPK9
  - MAPK10
  - IL6
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - NOS3
  - ENO4
  - P2RY2
  - MAPK3
  - TNF
  - PTK2
  - HCC
  - HYCC1
  - FLVCR1
  - COL9A3
  - DGCR2
  - TNF-a
  - PCa
  - Melanoma
---
